Status | Study |
Recruiting |
Study Name: Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease Condition: Dupuytren Contracture Dupuytren's Disease Date: 2016-12-17 Interventions: Procedure: Percutaneous Needle Aponeurotomy |
Recruiting |
Study Name: Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture Condition: Dupuytrens Contracture Date: 2015-06-05 Interventions: Drug: xiapex Other Name: clost |
Recruiting |
Study Name: Short-term Function and Pain After Treatment for Dupuytren's Disease Condition: Dupuytren Disease Date: 2014-07-11 Interventions: Procedure: Percutaneous Needle Aponeurotomy |
Withdrawn |
Study Name: Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease Condition: Dupuytren Contracture Date: 2013-01-17 Interventions: Drug: Collegenase injection |
Completed |
Study Name: CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment Condition: Dupuytren's Contracture Date: 2012-10-25 |
Completed |
Study Name: Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures Condition: Dupuytren's Contracture Date: 2012-08-27 Interventions: Biological: XIAFLEX / XIAPEX injection (0.58 mg after reconstitution with sterile diluent [0.3 mg/mL cal |
Completed |
Study Name: Collagenase Option for Reduction of Dupuytren's Contracture in Japan Condition: Dupuytren's Contracture Date: 2012-04-27 Interventions: Drug: Collagenase Clostridium Histolyticum AK160 (Collagenase Clostridium Histolyticum) 0.58 mg |
Completed |
Study Name: Registry of Dupuytren's Contracture Treatment Outcomes Condition: Dupuytren's Disease Date: 2012-03-28 |
Completed |
Study Name: Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture Condition: Dupuytrens Contracture Date: 2012-02-18 Interventions: Drug: Xiapex Collagenase Clost |
Completed |
Study Name: MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex Condition: Dupuytren's Disease Date: 2011-10-10 Interventions: Biological: XIAFLEX One Injection of 0.58 mg of Xiaflex into the affected area of the hand. |